1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR

GSK Plc - ADR

XNYS: GSK

Await Turnaround
Download real time

36.32 -0.03 (-0.08%)

2.0M XNYS Volume

XNYS 14 May, 2025 11:15 AM (EDT)

Watchlist

Portfolio

Share
73,779.1

Market Cap

High in industry
17.8

PE TTM

High in industry
-0.6

PEG TTM

PEG TTM is negative
3

Price to Book

Below industry Median
-0.1

Beta 1Year

Very Low volatility
Acquisition
GSK to acquire liver disease drug efimosfermin from Boston Pharmaceuticals for up to $2 billion See details

GSK Plc - ADR - GSK - stock price prediction, stock price target, analyst ratings from 8 analysts

GSK Plc - ADR has a share price target of US$ 42, revenue growth forecast of 9.3%, and profit growth estimate of 137.5% for FY25, based on top 8 analyst calls.

Forecaster Screeners